NEW YORK, March 1, 2017 /PRNewswire/ --
Stock-Callers.com has initiated reports coverage on Rite Aid Corp. (NYSE: RAD), Walgreens Boots Alliance Inc. (NASDAQ: WBA), Companhia Brasileira de Distribuicao (NYSE: CBD), and Casey's General Stores Inc. (NASDAQ: CASY). According to an article on CME Group released on February 03rd, 2017, business activity in the global Services sector accelerated to a 17-month high of 53.9 - up from 53.5 in December. The improved expansion rate was largely centered on the US and Russia. Learn more about these stocks by downloading their comprehensive and free reports at:
Camp Hill, Pennsylvania headquartered Rite Aid Corp.'s stock finished Tuesday's session flat at $6.00 with a total trading volume of 11.21 million shares. The Company's shares are trading 15.88% below their 50-day moving average. Shares of the Company, which through its subsidiaries, operates a chain of retail drugstores in the US, have a Relative Strength Index (RSI) of 42.14.
On February 15th, 2017, Rite Aid announced that naloxone, a medication that can be used to reverse the effects of an opioid overdose, is now available at more than 630 pharmacies in Georgia, Louisiana, Tennessee, Utah, Virginia, and West Virginia without a prescription, subject to state regulations. Previously, naloxone, which can be administered by injection or nasal spray, was only available with a physician's prescription. RAD complete research report is just a click away and free at:
Walgreens Boots Alliance
On Tuesday, shares in Deerfield, Illinois-based Walgreens Boots Alliance Inc. recorded a trading volume of 3.88 million shares. The stock ended the session 0.96% lower at $86.38. The Company's shares have advanced 6.47% in the last one month, 2.77% in the previous three months, and 4.85% on an YTD basis. The stock is trading 3.66% above its 50-day moving average and 6.32% above its 200-day moving average. Moreover, shares of Walgreens Boots Alliance, which operates as a pharmacy-led health and wellbeing Company, have an RSI of 65.81.
On February 06th, 2017, research firm Atlantic Equities upgraded the Company's stock rating from 'Neutral' to 'Overweight'.
On February 22nd, 2017, Walgreens Boots Alliance announced that it has designated more than 50 of its local specialty pharmacies as cancer-specialized locations led by pharmacists and pharmacy technicians who have advanced cancer training and expertise and are committed to making sure patients get the medications and answers they require when they need them. The Company noted that the pharmacy staff at these locations has completed a cancer-focused curriculum of advanced education courses, focused on colorectal, lung, prostate and breast cancer, as well as various blood cancers such as leukemia, lymphomas, multiple myeloma, myeloproliferative neoplasms and myelodysplatic syndrome. The complimentary report on WBA can be downloaded at:
Companhia Brasileira de Distribuicao
Shares in Sao Paulo, Brazil headquartered Companhia Brasileira de Distribuicao closed the day 2.48% lower at $18.12. The stock recorded a trading volume of 327,593 shares. The Company's shares have gained 11.03% in the previous three months and 9.49% on an YTD basis. The stock is trading 2.09% and 13.28% above its 50-day and 200-day moving averages, respectively. Additionally, shares of the Company, which engages in the retail of food, clothing, home appliances, electronics, and other products through its chain of hypermarkets, supermarkets, specialized stores, and department stores primarily in Brazil, have an RSI of 46.54.
On February 24th, 2017, the Company announced Q4 2016 gross revenue of R$12,741 million compared to gross revenue of R$11,329 in Q4 2015. The Company's Q4 2016 gross profit totaled R$2,701 million, with margin of 23.0%. In Q4 2016, the Company's adjusted EBITDA reached R$726 million, with margin of 6.2%. Sign up for your complimentary research report on CBD at:
Casey's General Stores
At the closing bell yesterday, shares in Ankeny, Iowa headquartered Casey's General Stores Inc. finished 2.72% lower at $114.58. The stock recorded a trading volume of 1.35 million shares, which was above its three months average volume of 514,100 shares. The Company's shares have advanced 2.45% in the last one month. The stock is trading below its 50-day moving average by 2.78%. Furthermore, shares of Casey's General Stores, which together with its subsidiaries, operates convenience stores under the Casey's General Store name in 14 Midwestern states, primarily in Iowa, Missouri, and Illinois, have an RSI of 39.77. Get free access to your research report on CASY at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44-330-808-3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA